Inhibition of Advanced Glycation End Products (AGEs) by Fermented Foods Using Lactic Acid Bacteria

Yuki Nakashima1,2, Hideki Kinoshita3,4

  • 1Graduate School of Bioscience, Tokai University, Kumamoto, Japan.

Insights

This study explores using lactic acid bacteria (LAB) to inhibit advanced glycation end products (AGEs) formation, which is linked to diabetes complications. Protocols are introduced for testing LAB

Area of Science:

  • Biochemistry
  • Microbiology
  • Food Science

Background:

  • Glycation is a nonenzymatic reaction between sugars and amines, forming advanced glycation end products (AGEs).
  • AGEs accumulation is linked to diabetes mellitus (DM) complications, particularly in hyperglycemic conditions.
  • Inhibiting AGEs formation is crucial for managing DM progression and related health issues.

Purpose of the Study:

  • To introduce protocols for assessing the efficacy of lactic acid bacteria (LAB) in inhibiting AGEs formation.
  • To identify specific LAB strains that can be used in fermented foods to mitigate AGEs accumulation.
  • To provide methods for evaluating LAB's impact on key AGEs markers like Nω-(carboxymethyl) arginine (CMA), Nε-(carboxymethyl) lysine (CML), and fluorescent AGEs.

Main Methods:

  • Development and description of inhibition assays for evaluating AGEs formation.
  • Utilizing LAB strains as potential inhibitors in fermented food matrices.
  • Quantification of specific AGEs (CMA, CML) and fluorescent AGEs using established biochemical assays.

Main Results:

  • The study outlines methodologies for quantifying AGEs inhibition by LAB.
  • The described protocols enable the screening of LAB for their anti-glycation properties.
  • This research lays the groundwork for developing functional fermented foods to combat AGEs.

Conclusions:

  • Lactic acid bacteria (LAB) show potential for inhibiting AGEs formation.
  • The developed protocols are essential for identifying effective LAB strains for functional foods.
  • Targeting AGEs through LAB fermentation may offer a strategy to reduce diabetes complications.